Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 06, 2020 09:25 ET | Source: CELIXIR Plc

Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001

Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001 First patient successfully dosed in cardiomyopathy study Stratford-upon-Avon, UK: July, 6 2019...
May 13, 2019 02:00 ET | Source: CELIXIR Plc

Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines

Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines Promising cancer gene therapy programme using small...
June 08, 2018 02:00 ET | Source: CELIXIR Plc

Celixir announces US FDA approval of the IND application for cell therapy Heartcel

Celixir announces US FDA approval of the IND application for cell therapy HeartcelTM FDA IND and UK MHRA CTA approval both achieved in H1 2018 Potentially pivotal heart failure trial of up to 250...
February 26, 2018 02:01 ET | Source: CELIXIR Plc

Celixir appoints Dr Mubasher Sheikh as Chairman of the Board

Celixir appoints Dr Mubasher Sheikh as Chairman of the Board Dr Fiona Murray, CBE, Professor Gary Pisano, Conor Kehoe and Professor Sir Martin Evans also join Celixir's Board ...
January 08, 2018 08:01 ET | Source: CELIXIR Plc

CELIXIR: CTA approval for potentially pivotal HeartcelTM Phase IIb trial

CTA approval for potentially pivotal HeartcelTM Phase IIb trial - Adult heart failure trial to complete in 2020 with potential market entry in 2021- Trial to be conducted at Imperial College...